It is a reference point. But the study is just 20 people and main study design was to ensure "safety" and "t-cell response" before moving to a larger study. There is more to be 'made' from the results of the infected than the non-infected.
Next study will use a much larger sample size.
In addition, hsv1 and hsv2 outbreaks can be largely caused by stress. If placebo group had reduction, likely accountable to reduction in stress.
Although, how would they even find a hsv2 placebo group? con some poor sucker into thinking he/she has hsv2!?
- Forums
- ASX - By Stock
- AVR
- Ann: HSV-2 Interim Results Announcement-AHZ.AX
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-54
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.00 |
Change
-0.560(4.46%) |
Mkt cap ! $253.4M |
Open | High | Low | Value | Volume |
$12.49 | $12.49 | $11.30 | $101.9K | 8.508K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 181 | $11.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.00 | 308 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 181 | 11.750 |
2 | 647 | 11.410 |
1 | 130 | 11.400 |
1 | 130 | 11.390 |
1 | 130 | 11.380 |
Price($) | Vol. | No. |
---|---|---|
12.000 | 308 | 2 |
12.300 | 505 | 1 |
12.490 | 1147 | 2 |
12.500 | 250 | 1 |
12.550 | 967 | 1 |
Last trade - 11.27am 04/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |